Affiliation:
1. The State Key Laboratory of Food Science and Technology Jiangnan University Wuxi Jiangsu China
2. Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province Jiangnan University Wuxi Jiangsu China
3. School of Food Science and Technology Jiangnan University Wuxi Jiangsu China
Abstract
AbstractThis study explores potential hypoglycemic mechanisms by preparing and identifying novel dipeptidyl peptidase IV (DPP‐IV) inhibitory peptides from goat milk (GM) whey protein. Papain was used to hydrolyze the GM whey protein. After purification by ultrafiltration, the Sephadex column, and preparative RP‐HPLC, the peptide inhibited DPP‐IV, α‐glucosidase, and α‐amylase with IC50 of 0.34, 0.37, and 0.72 mg/mL, respectively. To further explore the inhibitory mechanism of peptides on DPP‐IV, SPPEFLR, LDADGSY, YPVEPFT, and FNPTY were identified and synthesized for the first time, with IC50 values of 56.22, 52.16, 175.7, and 62.32 µM, respectively. Molecular docking and dynamics results show that SPPEFLR, LDADGSY, and FNPTY bind more tightly to the active pocket of DPP‐IV, which was consistent with the in vitro activity. Furthermore, the first three N‐terminals of SPPEFLR and FNPTY peptides exhibit proline characteristics and competitively inhibit DPP‐IV. Notably, the first N‐terminal leucine of LDADGSY may play a key role in inhibiting DPP‐IV.